相关实验视频

Updated: Jun 27, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

LAG-3:癌症组合疗法的最新发展

Aude Chavanton^1,2, Flavie Mialhe^1,2, Jimena Abrey^1,2

¹INSERM, UMR 1231, Laboratoire d'Excellence LipSTIC and « Equipe labellisée par la Ligue Nationale contre le Cancer », Dijon, France.

|May 4, 2024

概括

新的免疫疗法,如淋巴细胞激活基因3 (LAG-3) 抑制剂,对抗现有治疗方法的癌症患者显示出有前途. 将LAG-3抑制剂与其他疗法结合使用可能会改善抗瘤效果并扩大个性化药物选择.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

免疫检查点抑制剂 (ICI) 通过向T细胞抑制,改变了转移性癌症的治疗方法.
许多患者对当前的ICI如抗PD-1/PD-L1和抗CTLA-4表现出耐药性.
淋巴细胞激活基因3 (LAG-3) 是一个新兴的免疫检查点目标,有可能克服与癌症相关的免疫抵抗.

研究的目的:

审查当前关于LAG-3作为免疫治疗点的知识.
探索涉及LAG-3抑制剂与现有和新型治疗的组合策略.
突出新疗法组合的潜力,以扩大个性化癌症医学.

主要方法:

对LAG-3抑制剂的临床前和临床研究的文献综述.
专注于目前正在III期临床试验中的组合疗法.
在临床前阶段分析创新组合.

主要成果:

目前正在研究LAG-3抑制剂与化疗,免疫疗法,放射疗法和采用细胞疗法结合使用.
几种LAG-3抑制剂组合疗法正在进入III期临床试验.
临床前研究正在探索基于LAG-3的新型组合策略.

结论:

在克服抗癌免疫治疗的过程中,LAG-3是一个有前途的目标.
涉及LAG-3抑制剂的组合疗法有可能提高抗瘤疗效.
未来的研究可能会导致新的治疗组合,扩大个性化癌症治疗选择.

关键词:

现场行动小组-3 这就是TILs.对抗癌症的免疫反应.组合疗法组合疗法免疫疗法免疫疗法

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...